The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Kriger A.G.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Karmazanovskiĭ G.G.

FGBU "Institut khirurgii im. A.V. Vishnevskogo" Minzdrava Rossii, Moskva

Berelavichus S.V.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Gorin D.S.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Kaldarov A.R.

Institut khirurgii im. A.V. Vishnevskogo Minzdrava Rossii, Moskva

Panteleev V.I.

A.V. Vishnevsky Institute of Surgery, Moscow, Russia

Dvukhzhilov M.V.

Vishnevsky National Medical Research Center of Surgery of the Ministry of Health of the Russian Federation, Moscow, Russia

Kalinin D.V.

Institut khirurgii im. A.V. Vishnevskogo Minzdrava RF, Moskva

Glotov A.V.

Kafedra urologii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Zektser V.Yu.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

Duodenopancreatectomy for pancreatic tumors — pros and cons

Authors:

Kriger A.G., Karmazanovskiĭ G.G., Berelavichus S.V., Gorin D.S., Kaldarov A.R., Panteleev V.I., Dvukhzhilov M.V., Kalinin D.V., Glotov A.V., Zektser V.Yu.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2019;(12): 28‑36

DOI: 10.17116/hirurgia201912128

Read: 3055 times

Download PDF (RU)
Download PDF
Contact the author
Table of contents

DUODENOPANCREATECTOMY FOR PANCREATIC TUMORS — PROS AND CONS
DUODENOPANCREATECTOMY FOR PANCREATIC TUMORS — PROS AND CONS

To cite this article:

Kriger AG, Karmazanovskiĭ GG, Berelavichus SV, et al. . Duodenopancreatectomy for pancreatic tumors — pros and cons. Pirogov Russian Journal of Surgery. 2019;(12):28‑36. (In Russ., In Engl.)
https://doi.org/10.17116/hirurgia201912128

Подписка 2025-2 (Pirogov Russian Journal of Surgery)
МСФ на ЯМ
Использование инфографики авторами научных работ
Mediasphera_Net
Close metadata
Recommended articles:
Synchronous primary multiple cancer: distal cholangiocarcinoma of the intrapancreatic common bile duct and intraductal papi­llary muci­nous tumor asso­ciated with ductal adenocarcinoma of the pancreatic tail. Piro­gov Russian Journal of Surgery. 2024;(8):57-63
Robo­tic enucleation of pancreatic insu­linoma. Piro­gov Russian Journal of Surgery. 2024;(8):64-68
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Hemo­rrhage after pancreaticoduodenectomy. Piro­gov Russian Journal of Surgery. 2025;(1):14-21
Factors of delayed gastric emptying after pancreaticoduodenectomy. Piro­gov Russian Journal of Surgery. 2025;(4):23-29
Right-sided hemi­hepatectomy after endo­vascular vascular isolation of the right lobe of the liver. P.A. Herzen Journal of Onco­logy. 2024;(5):45-49
Solid pseudopapillary tumor of the pancreas. P.A. Herzen Journal of Onco­logy. 2024;(5):50-53

Objective. To optimize surgical treatment of multiple and advanced pancreatic tumors. Material and methods. There were 852 patients with various pancreatic tumors for the period 2011 — September 2019. Duodenopancreatectomy (DPE) was performed in 18 patients. Locally advanced ductal adenocarcinoma was diagnosed in 10 patients, acinar cell carcinoma — in 1 patient, multiple neuroendocrine tumors — in 4 cases, intraductal papillary mucinous tumor — in 2 patients, multiple metastases of renal cell carcinoma — in 1 patient. This procedure was avoided in 9 patients who underwent alternative operations: pancreatoduodenectomy (PDE) with pancreatic body resection for intraductal papillary mucinous tumor — 5 cases, two-stage (2) and one-stage (1) distal pancreatectomy and PDE for multiple neuroendocrine tumors — 2 patients, simultaneous pancreatic head resection and distal pancreatectomy for multiple metastases of renal cell carcinoma — 1 patient. Results. Postoperative complications occurred in 14 patients after DPE (77.8%) and in 5 patients after alternative operations (55.5%). Alternative procedures in patients with neuroendocrine tumors, intraductal papillary mucinous tumors and metastases of renal cell carcinoma ensured radical surgical treatment. These patients did not need for insulin replacement therapy and enzyme drugs. Conclusion. Strict adherence to oncological canons and differentiated approach in patients with multiple neuroendocrine tumors, metastases of renal cell carcinoma and intraductal papillary mucinous tumors are essential to avoid DPE in some cases in favor of alternative operations.

Keywords:

duodenopancreatectomy
total duodenopancreatectomy
pancreatoduodenectomy
pancreas

Authors:

Kriger A.G.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Karmazanovskiĭ G.G.

FGBU "Institut khirurgii im. A.V. Vishnevskogo" Minzdrava Rossii, Moskva

Berelavichus S.V.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Gorin D.S.

Institut khirurgii im. A.V. Vishnevskogo, Moskva

Kaldarov A.R.

Institut khirurgii im. A.V. Vishnevskogo Minzdrava Rossii, Moskva

Panteleev V.I.

A.V. Vishnevsky Institute of Surgery, Moscow, Russia

Dvukhzhilov M.V.

Vishnevsky National Medical Research Center of Surgery of the Ministry of Health of the Russian Federation, Moscow, Russia

Kalinin D.V.

Institut khirurgii im. A.V. Vishnevskogo Minzdrava RF, Moskva

Glotov A.V.

Kafedra urologii Moskovskogo gosudarstvennogo mediko-stomatologicheskogo universiteta

Zektser V.Yu.

I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia

List of references:

  1. Maker AV, Sheikh R, Bhagia V, et al. Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia. Langenbecks Arch Surg. 2017;402(6):873-883. https://doi.org/10.1007/s00423-017-1603-8
  2. Adeva-Andany MM, Funcasta-Calderón R, Fernández-Fernández C, et al. Metabolic effects of glucagon in humans. J Clin Transl Endocrinol. 2018;15:45-53. https://doi.org/10.1016/j.jcte.2018.12.005
  3. Del Chiaro M, Rangelova E, Segersvärd R, Arnelo U. Are there still indications for total pancreatectomy? Updates Surg. 2016;68(3):257-263. https://doi.org/10.1007/s13304-016-0388-6
  4. Casadei R, Ricci C, Taffurelli G, et al. Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study. J Gastrointest Surg. 2016;20(9):1595-1607. https://doi.org/10.1007/s11605-016-3201-4
  5. Revishvili AS, Kriger AG, Vishnevsky VA, et al. Current issues in pancreatic surgery. Khirurgiia (Mosk). 2018;(9):5-14. https://doi.org/10.17116/hirurgia20180915
  6. Suzuki S, Kajiyama H, Takemura A, et al. The Clinical Outcomes after Total Pancreatectomy. Dig Surg. 2017;34(2):142-150. https://doi.org/10.1159/000449234
  7. Nagtegaal ID, Odze RD, Klimstra D, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2019. https://doi.org/10.1111/his.13975
  8. Sanjay K, Chanjuan Shi. Protocol for the Examination of Specimens From Patients With Carcinoma of the Pancreas. College of American Pathologists. Version: Pancreas Exocrine 4.0.0.1 CAP; 2017.
  9. van Heerden JA. The first total pancreatectomy. Am J Surg. 1986;151(2):197-199. https://doi.org/10.1016/0002-9610(86)90068-1
  10. Kubyshkin VA, Kriger AG, Vishnevskiĭ VA, Pancreatectomy for the pancreatic tumors. Khirurgiia (Mosk). 2013;(3):11-16. PMID: 23612331. (In Russ.)
  11. Zakharova OP, Kubyshkin VA, Karmazanovskiĭ GG. The requirement for the CT-scan protocol for the proper assessment of pancreatic tumors resectability. Khirurgiia (Mosk). 2012;(8):44-50. PMID: 22968557. (In Russ.)
  12. Chakraborty J, Midya A, Gazit L, et al. CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas. Med Phys. 2018;45(11):5019-5029. https://doi.org/10.1002/mp.13159
  13. Xu W, Liu X, Zhang J, Yang L. Intraductal papillary mucinous neoplasms of the pancreas: correlation of helical Computed Tomography (CT) features with pathologic findings. Acad Radiol. 2017;24(5):609-614. https://doi.org/10.1016/j.acra.2016
  14. Berelavichus SV, Karmazanovskiĭ GG, Kriger AG, Fedorov AV, Shirokov VS, Kondrat’ev EV, Gorin DS. The virtual modeling of the robotic-assisted operations in abdominal surgery. Khirurgiia (mosk). 2011;6:18-21.
  15. Nakao A, Takeda S, Inoue S, et al. Indications and techniques of extended resection for pancreatic cancer. World j surg. 2006;30(6):976-982; discussion 983-984. https://doi.org/10.1007/s00268-005-0438-66
  16. Sanjay P, Takaori K, Govil S, et al. ‘Artery-first’ approaches to pancreatoduodenectomy. Br j surg. 2012;99(8):1027-1035. https://doi.org/10.1002/bjs.8763
  17. Zerbi A, Ortolano E, Balzano G, et al. Pancreatic metastasis from renal cell carcinoma: which patients benefit from surgical resection? Ann surg oncol. 2008;15(4):1161-1168. https://doi.org/10.1245/s10434-007-9782-0
  18. Kitade H, Yanagida H, Yamada M, et al. Pylorus-preserving total pancreatectomy for metastatic renal cell carcinoma: a case report. J med case rep. 2015;9:212. https://doi.org/10.1186/s13256-015-0654-0
  19. Scavini M, Dugnani E, Pasquale V, et al. Diabetes after pancreatic surgery: novel issues. Curr diab rep. 2015;15(4):16. https://doi.org/10.1007/s11892-015-0589-2

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.